Une grippe s’accompagne normalement des signes et symptômes suivants :
• début brutal, myalgies, céphalées, état fébrile
• mal de gorge modéré
• toux modérée, non productive, n’empêchant pas le patient
de dormir
• écoulement nasal bilatéral non purulent, avec éternuements,
sans céphalées localisées
• impossibilité d'avaler la salive
• dyspnée
• auscultation pulmonaire pathologique
• état confusionnel
• mauvais état général
• fièvre de plus de 38,5°C
• exsudats amygdaliens bilatéraux
• adénopathies bilatérales douloureuses
• absence de toux et de rhume
• écoulement nasal ou postérieur purulent
• céphalées localisées, frontales, maxillaires ou ethmoïdales
• inefficacité des décongestionnants nasaux
1Del Mar CB, Glasziou PP. Antibiotics for sore throat. In : Cochrane Library. Issue 4. Oxford : Update software, 1999.
2Smith MB, Fledman W. Over the counter cold medications, a critical review. JAMA 1993 ; 267.
3 Waldman, RJ, Hall, WN, McGee, H, Van Amburg, G. Aspirin as a risk factor in Reye’s syndrome. JAMA 1982 ; 247 : 3089.
4Eccles R, Moris S, Jawad M. Lack of effect of codeine in the treatment of cough associated with acute upper respiratory tract infection. J Clin Pharm Ther 1992 ; 17 : 175-80.
5Harper SA; Fukuda K ; Uyeki TM ; Cox NJ ; Bridges CB. Prevention and control of influenza : Recommendations of the Advisory Committee on Immunization Practices (ACIP). MWR Recomm Rep 2004 ; 53 : 1-40.
6Cooper NJ, Sutton AJ, Abrams KR, Wailoo A, Turner D, Nicholson KG. Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B : Systematic review and meta-analyses of randomised controlled trials. BMJ 2003 ; 326 : 1235.
7David DHo. Time to hit HIV, early and hard. N Engl J Med 1995 ; 333 : 450-1.
8Linder JA, Stafford RS. Antibiotic treatment of adults with sore throat by community primary care physicians. JAMA 2001 ; 286 : 1181-6.
9Aronson MD, Komaroff AL, Pass TM, Ervin CT, Branch WT. Heterophil antibody in adults with sore throat : Frequency and clinical presentation. Ann Intern Med 1982 ; 96 : 505-8.
10Centor RM, Witherspoon JM, Dalton HP, Brody CE, Link K. The diagnosis of strep throat in adults in the emergency room. Med Decis Making 1981 ; 1 : 239-46.
11Humair JP, Revaz SA, Bovier P, Stalder H. Management of acute pharyngitis in adults : Reliability of rapid streptococcal tests and clinical findings. Arch Intern Med 2006 ; 166 : 640-4.
12Centor RM, Brody CE, Link K, Witherspoon JM, Dalton HP. The diagnosis of strep throat in adults in the emergency room. Med Decis Making 1981 ; 1 : 239-46.
13Schmuziger N, Frei R, Hauser R, Wengen D, Probst R. Reliability of the rapid streptococcus a test. HNO 1996 ; 44 : 365-9.
14Dagnelie CF, van der Graaf Y, De Melker RA. Do patients with sore throat benefit from penicillin ? A randomized double-blind placebo-controlled clinical trial with penicillin V in general practice. Br J Gen Pract 1996 ; 46 : 589-93.
15Denny FW, Wannamaker LW. Prevention of RAA. Treatment of preceding streptococcal infection. JAMA 1950 ; 143 : 151-3.
16Zwart S, Sachs APE, Ruijs GJHM, et al. Penicillin for acute sore throat : Randomized double blind trial of seven days versus three days treatment or placebo in adults. BMJ 2000 ; 320 : 150-4.
17Spitzer TQ, Harris BA. Penicillin V therapy for streptococcal pharyngitis : Comparison of dosage schedules. South Med J 1977 ; 70 : 41-2.
18Feder HM Jr, Gerber MA, Randolph MF, Stelmach PS, Kaplan EL. Once-daily therapy for streptococcal pharyngitis with amoxicillin. Pediatrics 1999 ; 103 : 47-51.
19Schrock CG. Clarithromycin vs penicillin in the treatment of streptococcal pharyngitis. J Fam Pract 1992 ; 35 : 622-6.
20Cocuzza C, Blandino G, Mattina R, et al. Antibiotic susceptibility of group A streptococci in 2 Italian cities : Milano and Catania. Microb Drug Resist 1997 ; 3 : 379-84.
21Denny FW, Wannamaker LW. Prevention of RAA. Treatment of preceding streptococcal infection. JAMA 1950 ; 143 : 151-3.
22Schrock CG. Clarithromycin vs penicillin in the treatment of streptococcal pharyngitis. J Fam Pract 1992 ; 35 : 622-6.
23Stromberg A, Schwan A, Cars O. Five versus ten days treatment of group A streptococcal pharyngotonsillitis : A randomized controlled trial with phenoxymethylpenicillin and cefradoxil. Scand J Infect Dis 1988 ; 20 : 37-46.
24Zwart S, Sachs APE, Ruijs GJHM, et al. Penicillin for acute sore throat : Randomized double blind trial of seven days versus three days treatment or placebo in adults. BMJ 2000 ; 320 : 150-4.
25Schaad UB, Heynen G. Evaluation of the efficacy, safety and toleration of azithromycin vs. penicillin V in the treatment of acute streptococcal pharyngitis in children : Results of a multicenter, open comparative study. Pediatr Infect Dis J 1996 ; 15 : 791-5.
26Schwartz RH, Wientzen RL Jr, Pedreira F, Feroli EJ, Mella GW, Guandolo VL. Penicillin V for group A streptococcal pharyngotonsillitis. A randomized trial of seven vs ten days’ therapy. JAMA 1981 ; 246 : 1790-5.
27Little P, Williamson I, Warner G, Gould C, Gantley M, Kinmonth AL. Open randomised trial of prescribing strategies in managing sore throat. BMJ 1997 ; 314 : 722-7.
28Zwart S, Sachs APE, Ruijs GJHM, et al. Penicillin for acute sore throat : Randomized double blind trial of seven days versus three days treatment or placebo in adults. BMJ 2000 ; 320 : 150-4.
29Gwaltney JM. Acute community-acquired sinusitis. Clin Infect Dis 1996 ; 23 : 1209-23 ; quiz 1224-5.
30Hansen JG, Schmidt H, Rosborg J, Lund E. Predicting acute maxillary sinusitis in a general practice population. BMJ 1995 ; 311 : 233-6.
31Williams JW, Simel DL. Does this patient have sinusitis ? JAMA 1993 ; 270 : 1242-6.
32Hansen JG, Schmidt H, Rosborg J, Lund E. Predicting acute maxillary sinusitis in a general practice population. BMJ 1995 ; 311 : 233-6.
33De Sutter A, Lemiengre M, Van Maele G, et al. Predicting prognosis and effect of antibiotic treatment in rhinosinusitis. Ann Fam Med 2006 ; 4 : 484-5.
34Bucher HC, Tschudi P, Young J, et al. Effect of amoxicillin-clavulanate in clinically diagnosed acute rhinosinusitis : A placebo-controlled, double-blind, randomized trial in general practice. Arch Intern Med 2003 Aug 11-25 ; 163(15) : 1793-8.
35Van Buchem FL, Knottnerus JA, Schrijnemaekers VJ, Peeters MF. Primary-care-based randomised placebo-controlled trial of antibiotic treatment. Lancet 1997 ; 349 : 683-7.
36Wald ER, Chiponis D, Ledesma-Medina J. Comparative effectiveness of amoxicillin and amoxicillin-clavulanate potassium in acute paranasal sinus infections in children : A double-blind, placebo-controlled trial. Pediatrics 1986 ; 77 : 795-800.
37Varonen H, Rautakorpi UM, Huikko S, et al. Management of acute maxillary sinusitis in Finnish primary care. Results from the nationwide MIKSTRA study. Scand J Prim Health Care 2004 ; 22 : 122-7.
38Dolor RJ, Witsell DL, Hellkamp AS, Williams JW Jr, Califf RM, Simel DL. Comparison of cefuroxime with or without intranasal fluticasone for the treatment of rhinosinusitis. The CAFFS Trial : A randomized controlled trial. JAMA 2001 ; 286 : 3097-105.
39Hamory BH, Sande MA, Austin S Jr, Seale DL, Gwaltney JM. Etiology and antimicrobial therapy of acute maxillary sinusitis. J Infect Dis 1979 ; 139 : 5-10.
40Williams JW Jr, Holleman DR Jr, Samsa GP, Simel DL. Randomized controlled trial of 3 vs 10 days of trimethoprim/sulfamethoxazole for acute maxillary sinusitis. JAMA 1995 ; 273 : 1015-21.
41- Burke T, Villanueva C, Mariano H, Huck W, Orchard D, Haverstock D, et al. Comparison of moxifloxacin and cefuroxime axetil in the treatment of acute maxillary sinusitis. Clinical Therapeutics 1999 ; 21 : 1664-77.
